Lorlatinib and the Enigma of Autoantibody-Negative Diabetes

Patients on lorlatinib may develop diabetes with unusual characteristics, including the absence of typical autoantibodies. This presents a diagnostic challenge, requiring clinicians to consider drug-induced etiologies even when initial immunological markers are negative.

Smoking and Cataracts: A Clearer Vision of Prevention

Smoking-related cataracts contribute significantly to global vision impairment, a burden potentially reduced with aggressive smoking cessation strategies. Primary care physicians are uniquely positioned to communicate the tangible risk of vision loss to motivate patients towards quitting.

Hereditary Angioedema Prophylaxis: Weighing Berotralstat and Lanadelumab's Safety

For patients with hereditary angioedema, choosing a prophylactic therapy requires careful consideration of potential adverse events. A recent retrospective study sheds light on the safety profiles of berotralstat and lanadelumab, but inherent biases limit definitive conclusions.

Improving Pediatric Drug Hypersensitivity Diagnosis

Drug hypersensitivity reactions in children pose unique diagnostic challenges. New guidelines emphasize structured assessments and updated diagnostic criteria to improve accuracy and patient safety.

Infections in Ichthyosis: A Call for Vigilance

Patients with ALOX12B-associated autosomal recessive congenital ichthyosis face significant infectious risks beyond the skin. Clinicians should adopt proactive surveillance and management strategies, including early broad-spectrum antibiotics, to mitigate life-threatening complications.